Aerosolized antibiotic therapy: a forward aerial assault or forced contingency for ventilator-associated pneumonia?


The increasing prevalence and complexity of multipledrug-resistant (MDR) organisms in nosocomial infections have fueled interest in novel therapeutic approaches. Adjunctive aerosolized antibiotic (AAA) therapy for pneumonia has gained popularity, supported by apparent advantages of higher pulmonary antibiotic concentrations and lower systemic exposure… (More)
DOI: 10.4187/respcare.02016